We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

47 hedge funds and large institutions have $33.6M invested in Alimera Sciences in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 54 → 47 (-7)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

40% less capital invested

Capital invested by funds: $56.2M → $33.6M (-$22.6M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
47
Holders Change
-7
Holders Change %
-12.96%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
11
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$3.31M
2
AC
Armistice Capital
New York
+$888K
3
ACA
Avoro Capital Advisors
New York
+$561K
4
Renaissance Technologies
Renaissance Technologies
New York
+$72.7K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$61K

Top Sellers

Rank Fund Capital Flow
1
NRC
North Run Capital
Massachusetts
-$2.16M
2
JGC
J. Goldman & Co
New York
-$996K
3
GPP
Great Point Partners
Connecticut
-$420K
4
SFM
Sphera Funds Management
Israel
-$299K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$279K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$6.35M – – –
SCM
2
Stonepine Capital Management
Oregon
$4.99M +$3.31M +180,575 +142%
ACA
3
Avoro Capital Advisors
New York
$4.36M +$561K +30,633 +13%
AC
4
Armistice Capital
New York
$3.46M +$888K +48,533 +29%
PAI
5
Palo Alto Investors
California
$3.25M – – –
GPP
6
Great Point Partners
Connecticut
$2.48M -$420K -22,953 -13%
NRC
7
North Run Capital
Massachusetts
$1.87M -$2.16M -117,807 -51%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.67M -$279K -15,237 -13%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$1.09M +$9.87K +539 +0.8%
ACP
10
Acuta Capital Partners
California
$1.05M – – –
Goldman Sachs
11
Goldman Sachs
New York
$879K -$195K -10,633 -16%
BCM
12
Bridgeway Capital Management
Texas
$296K – – –
O
13
OrbiMed
New York
$270K – – –
PL
14
Parkwood LLC
Ohio
$246K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$174K +$18.8K +1,028 +11%
BFA
16
BlackRock Fund Advisors
California
$168K +$14.5K +791 +8%
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
$157K +$61K +3,333 +53%
SIM
18
Spark Investment Management
New York
$146K -$49.9K -2,726 -23%
Northern Trust
19
Northern Trust
Illinois
$115K +$1.37K +75 +1%
WMSA
20
Weiss Multi-Strategy Advisers
New York
$92K – – –
Renaissance Technologies
21
Renaissance Technologies
New York
$64K +$72.7K +3,973 New
SO
22
STRS Ohio
Ohio
$47K – – –
SCM
23
Southport Capital Management
Tennessee
$40K -$5.25K -287 -10%
Millennium Management
24
Millennium Management
New York
$37K -$87.4K -4,776 -68%
VKH
25
Virtu KCG Holdings
New York
$37K +$16K +872 +61%
1
2 3

ALIM Hedge Fund Activity: Q4 2016 in Review

47 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2016, worth a combined $33.6M — down 40% from $56.2M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ALIM and 6 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Stonepine Capital Management, adding an estimated $3.31M. The largest seller was North Run Capital, cutting an estimated $2.16M.

  • 47 institutional investors held Alimera Sciences (ALIM) as of Q4 2016, down from 54 in Q3 2016.
  • Funds reported $33.6M of Alimera Sciences stock for Q4 2016, down 40% quarter-over-quarter.
  • 6 funds opened new Alimera Sciences positions in Q4 2016 and 11 closed out, a net change of -5 holders.
  • The largest Alimera Sciences buyer in Q4 2016 was Stonepine Capital Management, an estimated $3.31M added.
  • The largest Alimera Sciences seller in Q4 2016 was North Run Capital, an estimated $2.16M sold.

Based on aggregated 13F filings for Q4 2016.